| Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer PS Rudland, A Platt-Higgins, M El-Tanani, S de Silva Rudland, ... Cancer research 62 (12), 3417-3427, 2002 | 430 | 2002 |
| Two separate mechanisms for ligand-independent activation of the estrogen receptor MKK El-Tanani, CD Green Molecular Endocrinology 11 (7), 928-937, 1997 | 243 | 1997 |
| The regulation and role of osteopontin in malignant transformation and cancer MK El-Tanani, FC Campbell, V Kurisetty, D Jin, M McCann, PS Rudland Cytokine & growth factor reviews 17 (6), 463-474, 2006 | 231 | 2006 |
| Ets gene PEA3 cooperates with β-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription M El-Tanani, A Platt-Higgins, PS Rudland, FC Campbell Journal of Biological Chemistry 279 (20), 20794-20806, 2004 | 145 | 2004 |
| The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control FC Campbell, H Xu, M El-Tanani, P Crowe, V Bingham Biochemical pharmacology 79 (1), 1-9, 2010 | 140 | 2010 |
| Corrugated microstrip coupled lines for constant absolute bandwidth tunable filters MA El-Tanani, GM Rebeiz IEEE Transactions on Microwave Theory and Techniques 58 (4), 956-963, 2010 | 138 | 2010 |
| Role of osteopontin in cellular signaling and metastatic phenotype MK El-Tanani Front Biosci 13 (4), 276, 2008 | 108 | 2008 |
| Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways HF Yuen, KK Chan, C Grills, JT Murray, A Platt-Higgins, OS Eldin, ... Clinical Cancer Research 18 (2), 380-391, 2012 | 107 | 2012 |
| Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation CK Mason, S McFarlane, PG Johnston, P Crowe, PJ Erwin, MM Domostoj, ... Molecular cancer therapeutics 7 (3), 548-558, 2008 | 106 | 2008 |
| DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma HF Yuen, YP Chan, S Law, G Srivastava, M El-Tanani, TW Mak, KW Chan Cancer Epidemiology Biomarkers & Prevention 17 (12), 3593-3602, 2008 | 101 | 2008 |
| Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line Z Shi, VM Hodges, EA Dunlop, MJ Percy, AP Maxwell, M El-Tanani, ... Molecular Cancer Research 8 (4), 615-626, 2010 | 95 | 2010 |
| Osteopontin as a target for cancer therapy NI Johnston, VK Gunasekharan, A Ravindranath, C O’Connell, ... Front Biosci 13 (4361), 72, 2008 | 91 | 2008 |
| Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells MKK El-Tanani, CD Green The Journal of steroid biochemistry and molecular biology 60 (5-6), 269-276, 1997 | 85 | 1997 |
| Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG Y Haggag, Y Abdel-Wahab, O Ojo, M Osman, S El-Gizawy, M El-Tanani, ... International journal of pharmaceutics 499 (1-2), 236-246, 2016 | 83 | 2016 |
| RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin VV Kurisetty, PG Johnston, N Johnston, P Erwin, P Crowe, DG Fernig, ... Oncogene 27 (57), 7139-7149, 2008 | 82 | 2008 |
| Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors M El-Tanani, DG Fernig, R Barraclough, C Green, P Rudland Journal of Biological Chemistry 276 (45), 41675-41682, 2001 | 82 | 2001 |
| Metastasis-inducing DNA regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4 M El-Tanani, R Barraclough, MC Wilkinson, PS Rudland Cancer research 61 (14), 5619-5629, 2001 | 80 | 2001 |
| Targeting HOX/PBX dimers in cancer R Morgan, M El-Tanani, KD Hunter, KJ Harrington, HS Pandha Oncotarget 8 (19), 32322, 2017 | 79 | 2017 |
| Ran GTPase in nuclear envelope formation and cancer metastasis KB Matchett, S McFarlane, SE Hamilton, YSA Eltuhamy, MA Davidson, ... Cancer Biology and the Nuclear Envelope: Recent Advances May Elucidate Past …, 2014 | 75 | 2014 |
| Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail‐induced epithelial–mesenchymal transition HF Yuen, YK Chan, C Grills, CM McCrudden, V Gunasekharan, Z Shi, ... The Journal of pathology 224 (1), 78-89, 2011 | 63 | 2011 |
Dr Murtaza TambuwalaAssociate Professor in Pharmacology and Therapeutics, University of LincolnDirección de correo verificada de lincoln.ac.uk
